Serum tissue polypeptide antigen in bladder cancer as a tumor marker: A prospective study

Journal of Clinical Oncology

Volumn 15, Issue 12, 1997, Pages 3446-3450

  Maulard Durdux, C ^a   Toubert, M E ^a   Hennequin, C ^a   Housset, M ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; APROTININ; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PROSTATE SPECIFIC ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD LEVEL; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME;

EID: 0030666793     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.12.3446     Document Type: Article

References (24)

1. Nathrath WBJ, Heidenkummer P, Björklund V, et al: Distribution of tissue polypeptide antigen (TPA) in normal human tissue: Immunohistochemical study on unfixed methanol-ethanol and formaline-fixed tissue. J Histochem Cytochem 33:99-109, 1985
2. Björklund B, Björklund V: The enigma of human tumor marker: TPA revised. Third International Conference on Human Tumor Markers: Biology and Clinical Applications, Naples, Italy, 1986
3. Mross KB, Wolfrum DI, Rauschecker H: Determination of tissue polypeptide antigen (TPA) levels in different cancer types and controls. Oncology 42:288-295, 1985
4. Ruibal A, Clotet B, Pigrau C, et al: Tissue polypeptide antigen in autoimmune diseases. Tumor Diagnostic Ther 3:40-45, 1982
5. Carbin BE, Collins VP, Ekman P: Tissue polypeptide antigen (TPA), some cytokeratins and epithelial membrane antigen (EMA) in normal, inflamed and malignant urothelium. Urol Res 15:191-194, 1987
6. Senatore S, Zizzi L, Blasi C, et al: Tissue polypeptide antigen (TPA) in urinary bladder cancer cytology: A follow-up study. Oncology 47:37-42, 1990
7. Carbin BE, Ekman P, Eneroth P, et al: Urine TPA (tissue polypeptide antigen) flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma. Urol Res 17:269-272, 1989
8. Adolphs HD, Oehr P: Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial baldder cancer. Urol Res 12:125-128, 1984
9. Oehr P, Vogel J, Maisey R, et al: TPA assay in diagnosis and follow-up of urinary bladder carcinomas, in Wust G (ed): Tumor Markers, Current Aspects and Clinical Relevance. Münster, Germany, 1986
10. Ruther U, Luthgen M, Baeurle K, et al: Surveillance and M-VEC therapy monotoring of patients with advanced carcinoma of the urinary tract by TPA. J Tumor Marker Oncol 4:303-306, 1989
11. Khanna OP, Wu B: Tissue polypeptide antigen (TPA) as predictor for genitourinary cancers and their metastases. Urology 30:106-110, 1987
12. Soloway MS, Freiha FS, DeVere White RW, et al: Tissue polypeptide antigen (TPA) immunoradiometric assay (IRMA) in regional and systemic staging of transitional cell carcinoma (TCC) of the urinary tract, in Klapdor R (ed): Current Tumor Diagnosis: Applications, Clinical Relevance, Research, Trends. Cancer of the Lung. State and Trends in Diagnosis and Therapy. New York, NY, Zuckschwerdt Verlag, 1994
13. Van Poppel H, Billen J, Goethuys H, et al: Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer. Anticancer Res (in press)
14. Maulard C, Toubert ME, Chretien Y, et al: Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker: A prospective study. Cancer 73:394-398, 1994
15. Oehr P, Westrour A, Derigs G, et al: Evaluation and characterization of tumor associated antigens by the inverse distribution function. Tumor Diagn 2:195-197, 1981
16. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
17. Cox DR: Regression models and life-table. J R Stat Soc B 34:187-202, 1972
18. Schlegel G, Lüthgens M, Eklund G, et al: Correlations between activity in breast cancer and CEA, TPA and eighteen common laboratory procedures and the improvement by the combined use of CEA and TPA. Tumor Diagnostik 2:6-11, 1981
19. Björklund B: Tissue polypeptide antigen, in von Kleist (ed): Critical Evaluation of Tumor Markers. Basel, Switzerland, Karger, 1981, pp 73-89
20. Schmidt A, Bub P, Rüther U, et al: Tissue polypeptide antigen for monitoring of advanced bladder cancer after MVEC chemotherapy. Eur Urol 21:10-12, 1992 (suppl 1)
21. Filella X, Menendez V, Molina R, et al: TPA prognostic value in superficial bladder cancer. Anticancer Res 15:123-125, 1995
22. Dexeus F, Logothetis C, Samuels ML, et al: Carcinoembryonic antigen and beta-human chorionic gonadotrophin as serum marker for advanced urothelial malignancies. J Urol 136:403-407, 1986
23. Pohl AL, Schweiger CHR, Manner G, et al: Selection of tumor markers by multivariate analysis for diagnosis of urinary bladder cancer. Proceedings of the Tenth International Association of Tumor Markers in Oncology, Bonn, Germany, September 1993 (abstr 34)
24. Pectasides D, Bafaloucos D, Antoniou F, et al: TPA, TATI, CEA, AFP, β-HCG, PSA, SCC and Ca19-9 for monitoring transitional cell carcinoma of the bladder. Am J Clin Oncol 19:271-277, 1996